Company profile

INTERACT Technology


Expertise: Sales, Business applications



Bio: INTERACT Technology is a global software company based in Sydney, Australia which identified a systematic gap in the provision of valuable, timely and optimal content and information to healthcare professionals.  myINTERACT was created to fill this gap which assists healthcare professionals in their daily duties and consequently enhances productivity and ultimately improves patient care.

INTERACT Technology continues to dedicate itself to understanding the digital needs of healthcare professionals and the requirements of the companies that engage with them – hospital departments, medical special interest groups, industry associations, event managers and pharmaceutical companies

myINTERACT is now used by many global pharmaceutical companies in over 25 countries and has won awards for innovation and customer engagement.
[Total: 0    Average: 0/5]

News & Trends - Medical Technology

MedTech News - Technology levels up support for healthcare employees - Matt Moran, MD, Philips

Technology levels up support for healthcare employees – Matt Moran, MD, Philips

Health Industry Hub | January 22, 2021 |

MedTech News: Matt Moran, Managing Director of Philips Australia & New Zealad, reflects on the impact of the COVID-19 pandemic […]

More


Medical

Aussie researchers receive $2.9m funding boost for multiple sclerosis

Health Industry Hub | January 22, 2021 |

Medical News: Twenty multiple sclerosis (MS) scientific research teams across the country will receive an important New Year funding injection […]

More


News & Trends - Biotechnology

Biotech News - AusBiotech renews agreements with international stakeholders

AusBiotech renews agreements with international stakeholders

Health Industry Hub | January 22, 2021 |

Biotech News: AusBiotech’s international partnerships have been extended, with new Memorandums of Understanding (MoU) signed with major international industry associations […]

More


News & Trends - Pharmaceuticals

Pharma News - AbbVie's phase 3 wins for Humira successor Skyrizi

AbbVie’s phase 3 wins for Humira successor Skyrizi

Health Industry Hub | January 22, 2021 |

Pharma News: AbbVie is in a race against time as patent expiry of its Humira inflammatory diseases blockbuster draws near […]

More